Gene-level analyses based on AML and SKAT-CR revealed that variation in ADAR was nominally associated (P < 0.05) with susceptibility to all invasive EOC, with P = 0.02 using both methods (Table 4). Here, ADAR is linked to acute myeloid leukemia.